Novartis Investigative Site

Belfast BT9 7AB

1 studies enrolling now · 13 studies all time

What they study most

Acute Myocardial Infarction, Breast Cancer, Colonic Neoplasms, Colorectal Neoplasms, Common Variable Immunodeficiency (CVID), APDS / PASLI, Cushing Disease, Cystic Fibrosis, IC-MPGN, Leukaemia, Lymphocytic, Chronic, Neoplasms, Breast, Primary Prevention of Atherosclerotic Cardiovascular Disease, Prostatic Neoplasms

Studies at this site

• Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN — Recruiting now
• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) — Running, not enrolling
• Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI — Completed
• Study of Efficacy of CDZ173 in Patients With APDS/PASLI — Completed
• Extension Study to Assess the Safety and Efficacy of Pasireotide in Participants With Cushing's Disease — Completed
• Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients — Stopped early
• Ofatumumab + Chlorambucil vs Chlorambucil Monotherapy in Previously Untreated Patients With Chronic Lymphocytic Leukemia — Stopped early
• Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer — Completed
• Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer — Completed
• EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer — APPROVED_FOR_MARKETING
• A Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) Patients — Completed
• Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis — Completed